290 related articles for article (PubMed ID: 15870833)
21. Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys.
Maguire DR; France CP
Behav Pharmacol; 2016 Apr; 27(2-3 Spec Issue):249-57. PubMed ID: 26397756
[TBL] [Abstract][Full Text] [Related]
22. Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates.
Cooper ZD; Evans SM; Foltin RW
Exp Clin Psychopharmacol; 2021 Apr; 29(2):137-146. PubMed ID: 34043398
[TBL] [Abstract][Full Text] [Related]
23. Reinforcing effects of opioid/cannabinoid mixtures in rhesus monkeys responding under a food/drug choice procedure.
Maguire DR; France CP
Psychopharmacology (Berl); 2018 Aug; 235(8):2357-2365. PubMed ID: 29860612
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
[TBL] [Abstract][Full Text] [Related]
25. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
Järbe TU; Lamb RJ; Lin S; Makriyannis A
Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
[TBL] [Abstract][Full Text] [Related]
26. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
Araya KA; David Pessoa Mahana C; González LG
Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
[TBL] [Abstract][Full Text] [Related]
28. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
[TBL] [Abstract][Full Text] [Related]
29. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Fattore L; Spano M; Melis V; Fadda P; Fratta W
Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
[TBL] [Abstract][Full Text] [Related]
30. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.
De Vry J; Jentzsch KR; Kuhl E; Eckel G
Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621
[TBL] [Abstract][Full Text] [Related]
31. Examination of the effects of cannabinoid ligands on decision making in a rat gambling task.
Ferland JN; Carr MR; Lee AM; Hoogeland ME; Winstanley CA; Pattij T
Pharmacol Biochem Behav; 2018 Jul; 170():87-97. PubMed ID: 29787777
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats.
De Vries TJ; Homberg JR; Binnekade R; Raasø H; Schoffelmeer ANM
Psychopharmacology (Berl); 2003 Jul; 168(1-2):164-169. PubMed ID: 12669182
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
34. Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine.
Achat-Mendes C; Valdez GR; Platt DM; Rowlett JK; Spealman RD
Psychopharmacology (Berl); 2009 Jun; 204(3):489-98. PubMed ID: 19225763
[TBL] [Abstract][Full Text] [Related]
35. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
36. The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.
Stewart JL; McMahon LR
Br J Pharmacol; 2011 Sep; 164(2b):655-66. PubMed ID: 21449917
[TBL] [Abstract][Full Text] [Related]
37. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
Sim-Selley LJ; Martin BR
J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
[TBL] [Abstract][Full Text] [Related]
38. Interactions between Δ(9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys.
Li JX; Koek W; France CP
Behav Pharmacol; 2012 Dec; 23(8):754-61. PubMed ID: 23044830
[TBL] [Abstract][Full Text] [Related]
39. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid-Induced Conditioned Place Preference, Intravenous Self-Administration, and Behavioral Stimulation Influenced by Ghrelin Receptor Antagonism in Rats.
Charalambous C; Havlickova T; Lapka M; Puskina N; Šlamberová R; Kuchar M; Sustkova-Fiserova M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
